Labetalol Hydrochloride NDC 70771-1163

Product information

Brand name (proprietary)

Labetalol Hydrochloride

Generic name (nonproprietary)

labetalol hydrochloride

Active ingredients

Labetalol hydrochloride — 100 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Zydus Lifesciences Limited

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207743

Marketing start

Dec 5, 2017

Listing expires

Dec 31, 2026

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 70771-1163_2be8d068-1830-4767-9e97-8d774d9a6001SPL ID 2be8d068-1830-4767-9e97-8d774d9a6001SPL set ID a3c0cc1e-1c01-4009-afdc-d35a66546aecRxCUI 896758, 896762, 896766UNII 1GEV3BAW9J

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771116301 followed by a unit qualifier and the quantity Copy

Package 70771-1163-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 207743

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.